lecanemab

Product

Anti-amyloid monoclonal antibody approved for early Alzheimer's disease treatment

4 stories

Study Finds Vaccine Reduces Alzheimer's Disease Risk by 55 Percent

Blood Test Identifies Dementia Risk in Women 25 Years Before Symptoms Emerge

Blood Tests Show Promise for Early Alzheimer's Detection

Simple Blood Test Can Predict Dementia 25 Years in Advance